ReviewJournal of clinical medicine2025
Non-Ossifying Fibromas: A 2025 Review.
Review in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Trametinib for multiple non-ossifying fibromas due to KRAS mosaic mutations: two case reports.Communications medicine · 2026Article
- Diagnostic and Treatment Strategies for Adult Non-Ossifying Fibromas: A Case Report and Literature Review.The American journal of case reports · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this comprehensive review, we explore the full spectrum of the most common incidentally found bone lesions in children and adolescents. Non-ossifying fibromas (NOFs) are benign, self-limiting bone lesions that represent a significant proportion of skeletal abnormalities in this population. Beginning with their first description by Sontag and Pyle and the subsequent histological characterization by Jaffe and Lichtenstein, we trace the historical evolution of understanding NOFs, including early theories on etiology, while outlining key epidemiologic, histopathologic, and advanced imaging findings. Furthermore, we discuss diagnostic criteria, management strategies, and emerging molecular insights for NOFs, emphasizing their clinical significance. By integrating historical perspectives, current diagnostic protocols, and emerging discoveries, this paper seeks to assist clinicians in optimizing diagnostic and treatment protocols to prevent unnecessary interventions through a comprehensive understanding of NOFs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.